Literature DB >> 17671701

Expression of Fhit, Mlh1, p16INK4A and E-cadherin in early gastric neoplasia: Correlation with histological grade and gastric phenotype.

Akihito Hara1, Kazuo Yashima, Akiko Yasugi, Masaharu Koda, Koichiro Kawaguchi, Kenichi Harada, Hironobu Andachi, Goshi Shiota, Hisao Ito, Yoshikazu Murawaki.   

Abstract

An increasing number of tumor suppressor genes (TSGs) that are inactivated by hypermethylation of CpG islands in the promoter have been reported in gastric carcinomas. The aim of this study is to evaluate the clinical significance of TSG protein expression, which correlates with the promoter status, methylated or not, during the early stages of gastric carcinogenesis and to examine its relationship with mucin phenotype. The protein expression of 4 TSGs including Fhit, Mlh1, p16INK4A and E-cadherin was examined using immunohistochemical methods in 103 early gastric neoplasias, comprising 41 adenomas and 62 intramucosal carcinomas, obtained by endoscopic mucosal resection. In addition, phenotypic expression patterns (gastric-, intestinal- and mixed-phenotypes) were also examined. The expression of Fhit, Mlh1, p16 and E-cadherin was lost or reduced in 7.3, 12.2, 12.2 and 9.8% of the adenomas and in 35.5, 29.0, 29.0 and 32.3% of the intramucosal carcinomas, respectively. The absent expression of p16 was significantly associated with the degree of dysplasia in the adenomas (p=0.038). The average number of proteins among the 4 TSGs, whose expression was lost or reduced per sample, was significantly higher in the intramucosal carcinomas (1.35) than in the adenomas (0.41) (p=0.00013). Similarly, the average number was significantly higher in the gastric-type tumors (2.05) than in the intestinal-type tumors (0.49) (p=0.0000019). We demonstrated an increase in the number of TSG proteins whose expression is reduced or lost in the early stages of gastric tumorigenesis, and that this increase is associated with histological grade and gastric phenotype.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17671701

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  4 in total

1.  Premalignant lesions in gastric cancer.

Authors:  Kazuo Yashima; Shuji Sasaki; Masaharu Koda; Koichiro Kawaguchi; Kenichi Harada; Yoshikazu Murawaki
Journal:  Clin J Gastroenterol       Date:  2009-12-16

2.  Clinicopathological and patient characteristics of early gastric neoplasia endoscopically resected with loss of Mlh1 expression.

Authors:  Shuji Sasaki; Kazuo Yashima; Akihiro Hayashi; Yohei Takeda; Akiko Yasugi; Masaharu Koda; Koichiro Kawaguchi; Kenichi Harada; Hisao Ito; Yoshikazu Murawaki
Journal:  Oncol Lett       Date:  2010-12-30       Impact factor: 2.967

3.  FHIT down-regulation was inversely linked to aggressive behaviors and adverse prognosis of gastric cancer: a meta- and bioinformatics analysis.

Authors:  Hua-Chuan Zheng; Li-Li Liu
Journal:  Oncotarget       Date:  2017-11-03

4.  HER-2/neu and E-cadherin Expression and Microsatellite Instability in Gastric Dysplasia.

Authors:  L Ahmadi; S Kamkari; P Mokarram; K Bagheri Lankarani; N Tabibi; H Ashktorab; M Vasei
Journal:  Middle East J Dig Dis       Date:  2011-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.